sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 24/05/2010
PIL Arava 20 mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 19/08/2009 and displayed until 24/05/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 16/05/2008 and displayed until 19/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 19/09/2007 and displayed until 16/05/2008
Reasons for adding or updating:
  • Change to Further Information section
Updated on 02/08/2006 and displayed until 19/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/08/2005 and displayed until 02/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/12/2000 and displayed until 04/08/2005
Reasons for adding or updating:
  • No reasons supplied
Updated on 18/01/2000 and displayed until 05/12/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   leflunomide